Pan-cancer analysis and KNSTRN as a potential prognosis biomarker

被引：0
|
作者：
Xiao, Shanshan [1 ]
Zou, Yuqing [1 ]
Wang, Li [1 ]
Wang, Qian [1 ]
Wang, Tao [1 ]
机构：
[1] Hangzhou Repugene Technol Co Ltd, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15180
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma
    Xu, Lei
    Shao, Fengling
    Luo, Tengling
    Li, Qijun
    Tan, Dongmei
    Tan, Yi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [32] Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers
    Wang, Yiyang
    Bi, Xiaojuan
    Luo, Zhiwen
    Wang, Haiyan
    Ismtula, Dilimulati
    Guo, Chenming
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [33] Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
    Huang, Tingting
    OuYang, XIaoxiao
    Li, Jiwei
    Shi, Bingbing
    Shan, Zhengda
    Shi, Zhiyuan
    Yang, Zhangru
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] A Comprehensive Pan-Cancer Analysis of the Potential Biological Functions and Prognosis Values of RICTOR
    Sun, Ying
    Li, Rui
    Nong, Baoting
    Zhou, Songyang
    Xianren, Wang
    Ma, Wenbin
    Zhou, Qin
    [J]. GENES, 2023, 14 (06)
  • [35] PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
    Wang, Qiankun
    Wang, Xiong
    Li, Jiaoyuan
    Yin, Tongxin
    Wang, Yi
    Cheng, Liming
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [36] PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
    Qiankun Wang
    Xiong Wang
    Jiaoyuan Li
    Tongxin Yin
    Yi Wang
    Liming Cheng
    [J]. Scientific Reports, 14
  • [37] Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
    Zheng, Haosheng
    Long, Guojie
    Zheng, Yuzhen
    Yang, Xingping
    Cai, Weijie
    He, Shiyun
    Qin, Xianyu
    Liao, Hongying
    [J]. CANCERS, 2022, 14 (21)
  • [38] RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
    Wu, Jintao
    Yu, Xinyu
    Zhu, Hongyu
    Chen, Peng
    Liu, Tongyan
    Yin, Rong
    Qiang, Yan
    Xu, Lin
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [39] HMMR potential as a diagnostic and prognostic biomarker of cancer-speculation based on a pan-cancer analysis
    Shang, Junyi
    Zhang, Xiaoju
    Hou, Guangjie
    Qi, Yong
    [J]. FRONTIERS IN SURGERY, 2023, 9
  • [40] Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration
    Liu, Yuying
    Huang, Hua
    Yang, Xijun
    Huang, Danhe
    Wang, Xiongwei
    Yuan, Mingyu
    Hong, Lianqing
    [J]. AGING-US, 2024, 16 (08): : 7437 - 7447
12345